Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.

@article{Miller2006HospitalCF,
  title={Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.},
  author={Leslie W. Miller and Karl E. Nelson and Robin R Bostic and Kuo Bianchini Tong and Mark S. Slaughter and James W Long},
  journal={The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation},
  year={2006},
  volume={25 7},
  pages={778-84}
}
BACKGROUND The use of left ventricular assist devices (LVADs) as an alternative to transplant, or destination therapy (end of life support), is an increasingly important option for patients with end-stage heart failure. Prior studies have examined hospital costs for LVAD implants performed during investigational studies (e.g., REMATCH), but none has been published since that trial was completed. METHODS We performed a retrospective analysis of 23 consecutive patients who had a HeartMate XVE… CONTINUE READING
23 Citations
18 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Complex - ity and cost of multi - drug regimens of older patients hospitalized for heart failure

  • FA Masoudi, CA Baille, HM Krumholtz
  • Arch Int Med
  • 2005

Similar Papers

Loading similar papers…